Princeton University

AskBio Names Mansuo Shannon Chief Scientific Officer

Retrieved on: 
Tuesday, April 9, 2024
Eli Lilly, Alzheimer's disease, Gene editing, Princeton University, MIT, Research, Bayer, Chugai Pharmaceutical Co., Doctor of Philosophy, Samulski, Therapy, Eli Lilly and Company, CSO, Molecular biology, Management

Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company

Key Points: 
  • Shannon joins AskBio from Prevail Therapeutics, a wholly owned subsidiary of Eli Lilly and Company
    Co-Founder and former Chief Scientific Officer R. Jude Samulski to remain member of AskBio Board of Directors
    Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, announced today that on April 8, 2024, Mansuo Shannon, PhD, was named the company’s next Chief Scientific Officer (CSO).
  • Shannon joins AskBio from Prevail Therapeutics, where she also served as CSO.
  • Reporting to Gustavo Pesquin, Chief Executive Officer (CEO), Shannon will be a member of AskBio’s Executive Leadership Team and head its R&D organization.
  • As part of her role as CSO at AskBio, Shannon will develop and implement the company’s future R&D strategy.

OncoC4 Expands Scientific Advisory Board with Appointment of Heather A. Wakelee, MD, FASCO

Retrieved on: 
Tuesday, April 2, 2024
Lung cancer, Internal medicine, Stanford Cancer Institute, Entrepreneurship, Princeton University, Immunotherapy, Oncology, International Association, Research, Cancer, Doctor of Philosophy, MD, Mesothelioma, CD24, MacArthur Fellows Program, Johns Hopkins University, Principal investigator, SAB, Division, Stanford University, CSO, Thymoma, Pharmaceutical industry

“We are honored to welcome Heather to the OncoC4 SAB, an international expert with decades of leadership experience in the treatment of lung cancer,” said Yang Liu, PhD, Co-Founder, CEO and CSO of OncoC4.

Key Points: 
  • “We are honored to welcome Heather to the OncoC4 SAB, an international expert with decades of leadership experience in the treatment of lung cancer,” said Yang Liu, PhD, Co-Founder, CEO and CSO of OncoC4.
  • By leveraging universal pathways, OncoC4 has the potential to change the treatment paradigm for many common and aggressive cancers with high unmet needs.
  • Currently she serves as Deputy Director of the Stanford Cancer Institute and is the Division Chief of Medical Oncology.
  • She is the Principal Investigator on numerous clinical trials and has held advisory board roles with multiple international pharmaceutical companies.

New MIT Sloan research: AI-generated visuals of reimagined sustainable cities enhanced Americans' willingness to support green transportation policies

Retrieved on: 
Thursday, March 28, 2024
Climate change, Princeton University, Research, Policy, Transport, AI, Management, Doctor of Philosophy, Republican, Life, I-35, Psychology, City, Imagination, Marketing, Nature Sustainability

The research paper, AI-generated visuals of car-free US cities help improve support for sustainable policies , published in Nature Sustainability combines insights from behavioral science with recent advances in AI.

Key Points: 
  • The research paper, AI-generated visuals of car-free US cities help improve support for sustainable policies , published in Nature Sustainability combines insights from behavioral science with recent advances in AI.
  • The study was led by Rachit Dubey, a postdoctoral research fellow at MIT’s Sloan School of Management in collaboration with Rahul Bhui, assistant professor of marketing at MIT Sloan.
  • “America’s infrastructure is extremely car-centric, so using more sustainable modes of transportation is currently inconvenient or unavailable to many people,” said Dubey.
  • “We need to show people how much better their life will be if a green or a sustainable policy were passed.”

American Water Contributes Expertise at the Andlinger Center for Energy and the Environment Summit at Princeton University

Retrieved on: 
Tuesday, April 9, 2024
Environment, Finance, Environmental Issues, Other Energy, Utilities, Banking, Professional Services, Sustainability, Energy, Water, National Association, PFAS, Faculty, Princeton University

American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., announced today that it will participate in the Andlinger Center for Energy and the Environment Summit on PFAS in Biosolids and Soils, taking place April 12, 2024, at Princeton University.

Key Points: 
  • American Water (NYSE: AWK), the largest regulated water and wastewater utility company in the U.S., announced today that it will participate in the Andlinger Center for Energy and the Environment Summit on PFAS in Biosolids and Soils, taking place April 12, 2024, at Princeton University.
  • Lynda DiMenna, Vice President, Chief Environmental Officer, American Water, will join moderator Robert Powelson, President and Chief Executive Officer, National Association of Water Companies, for a discussion titled, Stakeholder Perspectives: Utilities.
  • DiMenna, along with other expert panelists, will discuss how utilities are faced with important questions and challenging decisions to make about how they will manage PFAS over the coming years.
  • This one-day summit aims to gather industry leaders, researchers, and faculty who are actively working on PFAS-related projects.

C2Sense® and Princeton BioMeditech Receive Second Award from NIH RADx® Tech High Performance Program for Digitally Connected, At-Home Diagnostic Reader and Multiplex COVID-19/Flu A&B Rapid Test

Retrieved on: 
Tuesday, April 9, 2024
Medical imaging, ACME, Halo, Human services, SARS-CoV-2, NIH, Acceleration, Clinical trial, National Institutes of Health, POC, BBC, Omicron, Biological engineering, Bangladesh Technical Education Board, Federal, Health department, PBM, Princeton University

The companies are currently planning their upcoming clinical trial, regulatory submission, and transfer to manufacture.

Key Points: 
  • The companies are currently planning their upcoming clinical trial, regulatory submission, and transfer to manufacture.
  • "After rigorous testing and intensive data collection, Halo®, used in conjunction with the PBM multiplex rapid test, continues to demonstrate outstanding sensitivity and reliability," said Jason Cox, Ph.D., CEO at C2Sense.
  • "Powered by our latest algorithm release, the price vs. performance of our Halo reader is unparalleled."
  • As always, we remain committed to providing our customers with the best possible solution for at-home testing," added Cox.

CHARM Therapeutics Announces Foundation of Scientific Advisory Board (SAB)

Retrieved on: 
Tuesday, March 19, 2024
College, PI3, Data science, Machine, Deep learning, Therapy, Harvard University, Audit trail, Membrane protein, School, Statistics, Biotechnology, ICR, Electrical engineering, Princeton University, 3D, Dartmouth College, Breast cancer, SAB, Applied science, Drug resistance, Royal, Machine learning, Computer science, Drug discovery, Associate, Royal Society, Intelligence, Research, AKT, Cancer, University, Cancer research, DARPA, Howard Hughes Medical Institute, Drug development, Principal, AstraZeneca, Entrepreneurship, The Institute, Biomarker, Columbia University, Faculty, Saint John's College, Stanford University, Chemical engineering, Medicine, Management

LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and developing transformational medicines, today announces the foundation of its Scientific Advisory Board (SAB) to provide expert insight and guidance to the Company on the optimal application of 3D deep learning, protein design and prediction in real world medicine.

Key Points: 
  • LONDON – 19 March 2024 -- CHARM Therapeutics (“CHARM”, “The Company”), a 3D deep-learning research company discovering and developing transformational medicines, today announces the foundation of its Scientific Advisory Board (SAB) to provide expert insight and guidance to the Company on the optimal application of 3D deep learning, protein design and prediction in real world medicine.
  • This pioneering technology enables CHARM to target and develop treatments for previously hard-to-drug targets in cancer and other therapeutic areas.
  • Laksh Aithani, Co-Founder, Chief Executive Officer and Board Member of CHARM Therapeutics, said: “As CHARM advances its 3D deep learning platform in discovery it’s critical to maintain aligned oversight of our priorities and keep abreast of this emerging field.
  • Founding members of CHARM’s SAB:
    David Baker, Ph.D. is a Scientific Co-Founder at CHARM and Chair of the SAB.

Stellarex, Inc. and Canadian Nuclear Laboratories Sign MOU to Collaborate on the Development of Fusion Energy

Retrieved on: 
Monday, March 18, 2024
Hydrogen, Tritium, MOU, Princeton University, Deuterium, CNL, Lithium

Under the terms of the collaboration, Stellarex and CNL will partner in specific areas of fusion energy science and technology towards the design and realization of Stellarex’s planned fusion energy power plants.

Key Points: 
  • Under the terms of the collaboration, Stellarex and CNL will partner in specific areas of fusion energy science and technology towards the design and realization of Stellarex’s planned fusion energy power plants.
  • "Stellarex is delighted to be collaborating with Canadian Nuclear Laboratories,” said Professor Amitava Bhattacharjee, Co-Founder and Chief Science Officer of Stellarex, also of Princeton University.
  • "CNL has exceptional experience in many key areas of importance in developing our stellarator fusion energy devices."
  • “Canada is in the midst of rapidly growing our work in fusion energy technologies, and CNL is excited to partner with Stellarex in its pursuit of a magnetic fusion energy based on the stellarator approach,” said Dr. Stephen Bushby, Vice-President, Science and Technology, Canadian Nuclear Laboratories.

Collective Metals Provides Review of Fourteen Mile Target Area on its Princeton Property, B.C.

Retrieved on: 
Friday, March 15, 2024
Agreement, Property, MPD, Geology, RMK, IP, Marketing, 3B2, CAD, Project, Arsenic, CMMC, Anomaly, Mineral, Whipsaw Creek, Term, Ministry, Iron, Gravity anomaly, Bismuth, Princeton Project, News, Metallurgy, National instrument, Google Ads, Soil, Service, COMT, Corridor, Advertising, Princeton University, Element, Mechanical engineering, Donald Duck filmography, Cobalt, Rare-earth element

VANCOUVER, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- COLLECTIVE METALS INC. (CSE: COMT | OTC: CLLMF | FSE: TO1) (the “Company” or “Collective”) is pleased to provide a review of results from the Fourteen and Fifteen Mile target areas in its flagship Princeton Project in south-central B.C. (the “Project”). The Property hosts several alkalic Cu-Au porphyry targets associated with Triassic diorite intrusions analogous to those associated with the currently producing Copper Mountain Mine, which lies approximately 10 km to the east (Figure 1). Results from a soil geochemical survey completed in 2023 are interpreted to confirm the mineral potential of the Fourteen and Fifteen Mile target areas as one of five (5) promising prospects with favourable geology, geophysical signatures, and/or historic geochemistry (please see News Release dated January 8, 2024). The Trojan-Condor Corridor, which hosts significant chargeability anomalies identified in a previous Induced Polarization (“IP”) survey,1 is considered a drill-ready target. The Company plans to conduct IP surveys over the other four target areas, including the Fourteen Mile target, in 2024.

Key Points: 
  • VANCOUVER, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- COLLECTIVE METALS INC. (CSE: COMT | OTC: CLLMF | FSE: TO1 ) (the “Company” or “Collective”) is pleased to provide a review of results from the Fourteen and Fifteen Mile target areas in its flagship Princeton Project in south-central B.C.
  • The Trojan-Condor Corridor, which hosts significant chargeability anomalies identified in a previous Induced Polarization (“IP”) survey,1 is considered a drill-ready target.
  • The Company plans to conduct IP surveys over the other four target areas, including the Fourteen Mile target, in 2024.
  • Figure 1 - Fourteen, Fifteen and Sixteen Mile Target Areas with Aeromagnetic anomalies, alteration, intrusions, 2011 high-quality sieved sediment samples and 2023 soil pathfinder anomaly geochemistry.

Ellie McDonald and Jeannine Sargent Join G2 Venture Partners

Retrieved on: 
Wednesday, April 3, 2024
Environment, Climate Change, Finance, Professional Services, Business, Sustainability, Alternative Energy, Green Technology, Start-Up, Energy, Research, Flex, TEL Solar, Fortive, Growth, Princeton University, Synopsys, MIT, University, Harvard University, Climate, Operations research, Stanford University, MSIP, Investment, Chemical engineering, G2, Engineering, Power, Barclays, Renewable energy

G2 Venture Partners , a venture capital firm investing in transformative technology companies at their inflection points to build a sustainable future, today announced that Ellie McDonald and Jeannine Sargent have joined the firm.

Key Points: 
  • G2 Venture Partners , a venture capital firm investing in transformative technology companies at their inflection points to build a sustainable future, today announced that Ellie McDonald and Jeannine Sargent have joined the firm.
  • Ellie McDonald joins G2 Venture Partners as an Investor, having spent the past seven years working across investment and engineering disciplines.
  • Prior to joining G2, Ellie was a Private Equity Associate at Morgan Stanley Infrastructure Partners (MSIP), primarily investing in the energy and telecommunication sectors.
  • “We are thrilled to welcome the unique perspectives and deep experience that both Ellie and Jeannine bring to our talented team,” said Brook Porter, Founding Partner at G2.

Brightcore Energy Developing 2.2MW Solar Project Portfolio on Princeton University Campus

Retrieved on: 
Tuesday, April 2, 2024
Other Energy, Sustainability, Alternative Energy, Energy, Other Education, Commercial Building & Real Estate, Environment, University, Construction & Property, Education, Green Technology, Building Systems, Carbon, Electricity, Princeton University, CUB, Stadium, CO2, TIGER, Coal, Meadow, Renewable energy

Brightcore Energy, a leader in developing and implementing renewable energy solutions for the commercial and institutional markets, is developing a portfolio of solar projects for the Facilities Organization at Princeton University which will be installed on rooftop and canopy- mounted structures on the University’s campus in Princeton N.J.

Key Points: 
  • Brightcore Energy, a leader in developing and implementing renewable energy solutions for the commercial and institutional markets, is developing a portfolio of solar projects for the Facilities Organization at Princeton University which will be installed on rooftop and canopy- mounted structures on the University’s campus in Princeton N.J.
  • The project consists of four arrays, two of which will be rooftop-mounted and two canopy-mounted.
  • “We are so very proud to have been selected for this project,” said Mike Richter, President of Brightcore.
  • A key component of Princeton’s Sustainability Action Plan is using renewables as the campus energy source.